Table 1.

Clinical characteristics of multiple myeloma patients (immunoglobulins used in osteoclast assays)

CharacteristicIsolation of the M componentIsolation of uninvolved immunoglobulins
Without BD (n = 10)With BD (n = 16)Without BD (n = 10)With BD (n = 17)
Age (median), y 67.7 (44-78) 67 (49-79) 70.1 (61-78) 62.7 (30-81) 
Sex (male) 7 (70%) 6 (38%) 7 (70%) 11 (64.7%) 
Female 10 
ISS 1 
ISS 2 
ISS 3  
Unknown 12 
HB, g/L 12.1 (9.3-13.8) 11.0 (6.3-14.2) 10.9 (8.8-14.3) 10.2 (5.9-14.9) 
WBC (/L) 5.5 (2.2-11.3) 4.8 (1.8-8.1) 8.8 (3.8-13.2) 8.4 (3.2-14.9) 
TRC (/L) 264 (154-406) 191 (5-296) 229 (129-336) 233 (120-412) 
M component, g/L 20.8 (3.5-42) 29.9 (8-71.9) 23.8 (2.5-44) 21.9 (0-63) 
% PC 20 (9-44) 35 (2-95) 35 (10-65) 41 (6-83) 
Light chain κ 5 (50%) 12 (75%) 10 (100%) 13 (76.4%)* 
CharacteristicIsolation of the M componentIsolation of uninvolved immunoglobulins
Without BD (n = 10)With BD (n = 16)Without BD (n = 10)With BD (n = 17)
Age (median), y 67.7 (44-78) 67 (49-79) 70.1 (61-78) 62.7 (30-81) 
Sex (male) 7 (70%) 6 (38%) 7 (70%) 11 (64.7%) 
Female 10 
ISS 1 
ISS 2 
ISS 3  
Unknown 12 
HB, g/L 12.1 (9.3-13.8) 11.0 (6.3-14.2) 10.9 (8.8-14.3) 10.2 (5.9-14.9) 
WBC (/L) 5.5 (2.2-11.3) 4.8 (1.8-8.1) 8.8 (3.8-13.2) 8.4 (3.2-14.9) 
TRC (/L) 264 (154-406) 191 (5-296) 229 (129-336) 233 (120-412) 
M component, g/L 20.8 (3.5-42) 29.9 (8-71.9) 23.8 (2.5-44) 21.9 (0-63) 
% PC 20 (9-44) 35 (2-95) 35 (10-65) 41 (6-83) 
Light chain κ 5 (50%) 12 (75%) 10 (100%) 13 (76.4%)* 

% PC, % plasma cells; ISS, International Staging System; HB, hemoglobin; TRC, number of thrombocytes; WBC, white blood cells.

*

The rest is nonsecretory.

or Create an Account

Close Modal
Close Modal